ダウンロード数: 1236
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
67_10_465.pdf | 1.04 MB | Adobe PDF | 見る/開く |
タイトル: | 前立腺神経内分泌癌の1例 |
その他のタイトル: | Neuroendocrine Differentiation of Prostate Cancer : A Case Report |
著者: | 高見澤, 重彰 斑目, 旬 小林, 徳朗 倉内, 崇至 前田, 重孝 中條, 洋 松原, 伸晃 木村, 高弘 頴川, 晋 |
著者名の別形: | TAKAMIZAWA, Shigeaki MADARAME, Jun KOBAYASHI, Tokuro KURAUCHI, Takashi MAEDA, Shigetaka NAKAJO, Hiroshi MATSUBARA, Nobuaki KIMURA, Takahiro EGAWA, Shin |
キーワード: | Neuroendocrine differentiation Prostate cancer |
発行日: | 31-Oct-2021 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 67 |
号: | 10 |
開始ページ: | 465 |
終了ページ: | 469 |
抄録: | A 79-year-old man underwent a transrectal prostate needle biopsy with a prostate-specific antigen (PSA) level of 12.0 ng/ml. He was diagnosed with adenocarcinoma (Gleason score 4+3, cT3aN0M0) and underwent radiation therapy. Eight months later, he was administered hormone therapy because of a rise in PSA level to 8.4 ng/ml. One year and 5 months later, he experienced back pain, and computed tomography revealed multiple lymphadenopathies and irregular prostate enlargement. The PSA level was 0.097 ng/ml. Re-biopsy of the prostate and biopsy of the lymph node were performed. Pathological examination revealed neuroendocrine differentiation of the prostate. The disease progressed rapidly, and the patient died 4 months after the biopsy. Neuroendocrine differentiation of prostate cancer is rare, and its development may not be consistent with PSA levels. Therefore, periodic imaging examinations should be conducted, even when PSA levels are low. |
著作権等: | 許諾条件により本文は2022-11-01に公開 |
DOI: | 10.14989/ActaUrolJap_67_10_465 |
URI: | http://hdl.handle.net/2433/265868 |
PubMed ID: | 34742172 |
出現コレクション: | Vol.67 No.10 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。